Smarter Investing

Here's why we took a position in the iShares NASDAQ Biotechnology Index.

Strategies

Why biotech trumps big pharma in our portfolio

These misunderstandings aren't helping anyone.

Outlook

Not only did hedge funds as a class underperform the S&P 500 by fully 10% through May 10, but only a small sliver of funds managed to outperform it.

Outlook

Steer clear of gold, which may be set for more declines.

Strategies

Here's how the Net Payout Yields portfolio performed.

Strategies

Yahoo will acquire massive traffic gains in this $1.1 billion deal.

Outlook

The Barrack Yard portfolio manager talks international investing on Enterprise Radio.

Strategies

"I've been all dollar, all the time."

Outlook

Drones will emerge as a big investment sector.

Strategies

Here's how the key holdings performed.

Strategies

Oracle is a cloud computing leader with plenty of free cash flow.

Strategies

Some of these “smart money” guys haven’t been looking too smart of late.

Strategies